• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Ozempic v. Mounjaro? There’s a clear winner for weight loss, study finds

Ozempic v. Mounjaro? There’s a clear winner for weight loss, study finds

by Ryan Klingler | Jul 8, 2024 | Media

Mounjaro leads to significantly more weight loss than Ozempic, study suggests

Mounjaro leads to significantly more weight loss than Ozempic, study suggests

by Ryan Klingler | Jul 8, 2024 | Media

Mounjaro leads to significantly more weight loss than Ozempic, study suggests

CNN Exclusive: Adderall prescriptions have been filled less often amid ongoing shortage in the US

by Ryan Klingler | Apr 2, 2024 | Media

Next Entries »

Share this


Recent posts

  • Linking patient records at scale: New hybrid approach from Truveta
  • Accelerating clinical trial recruitment: From feasibility analysis to site activation
  • Studying substance use disorder in real-world care

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.